EXACT Sciences Corp.

48
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US30063P1057
USD
103.85
0.28 (0.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
EXACT Sciences Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-203.00
-1,036.00
-201.00
-632.00
-842.00
-857.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
121.00
-56.00
0.00
-26.00
111.00
-42.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
491.00
210.00
156.00
-223.00
-102.00
136.00
Cash Flow from Investing Activities
195.00
-442.00
49.00
74.00
-1,082.00
-702.00
Cash Flow from Financing Activities
-338.00
231.00
159.00
76.00
8.00
1,879.00
Net Cash Inflow / Outflow
349.00
-3.00
366.00
-72.00
-1,175.00
1,314.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-3.00
1.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of EXACT Sciences Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-203.888
268.277
-471.00
-176.00%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
121.825
-96.781
217.00
225.88%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
491.438
580.459
-89.00
-15.34%
Cash Flow from Investing Activities
195.121
-17.353
212.00
1224.42%
Cash Flow from Financing Activities
-338.09
-855.049
517.00
60.46%
Net Cash Inflow / Outflow
349.36
-243.422
592.00
243.52%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.891
48.521
-48.00
-98.16%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 133.42% vs 34.86% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
491.44
210.54
133.42%